
Multiomic Health
"AI-enabled precision medicine for cardio-renal-metabolic disease"
Profile written from public sources. Claim it for free
About Multiomic Health
Multiomic Health develops precision therapeutics for age-related chronic diseases where genetics alone cannot explain continued progression despite standard treatment. Founded in 2021 and based in London, it focuses on cardio-renal-metabolic conditions, particularly chronic kidney disease. The company describes this wider disease group as affecting more than two billion people and costing $2 trillion globally in 2019.
Its platform combines longitudinal patient records, multi-omics data, AI-enabled analysis and experimental biology to identify patient subpopulations with distinct molecular disease drivers. This work supports the development of targeted treatments and associated diagnostics. Multiomic is also building a global cardio-renal-metabolic patient registry, with a stated target of capturing more than 100,000 patients by 2028.

- Focus
- Cardio-renal-metabolic disease
- Founded
- 2021
Scientific and commercial teams
Multiomic combines clinical research, translational science, data science and computational biology with business development and partnership functions. Its operating-team structure brings these specialisms together around its precision-medicine programmes, with scientific advisers contributing additional expertise.

Open Positions
Join our team! Explore current opportunities at Multiomic Health.
No open positions at the moment.
Check back soon for new opportunities!